Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $42.36 USD
Change Today +0.99 / 2.39%
Volume 336.0K
PBH On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:06 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

prestige brands holdings inc (PBH) Snapshot

Open
$41.33
Previous Close
$41.37
Day High
$42.68
Day Low
$41.01
52 Week High
03/20/15 - $42.88
52 Week Low
04/11/14 - $25.94
Market Cap
2.2B
Average Volume 10 Days
391.1K
EPS TTM
$1.54
Shares Outstanding
52.3M
EX-Date
--
P/E TM
27.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for PRESTIGE BRANDS HOLDINGS INC (PBH)

Related News

No related news articles were found.

prestige brands holdings inc (PBH) Related Businessweek News

View More BusinessWeek News

prestige brands holdings inc (PBH) Details

Prestige Brands Holdings, Inc., through its subsidiaries, is engaged in the marketing, sale, and distribution of over-the-counter (OTC) healthcare and household cleaning products in North America and internationally. It operates through two segments, Over-The-Counter Healthcare and Household Cleaning. The Over-The-Counter Healthcare segment offers a portfolio of OTC products under 14 primary OTC brands, including Chloraseptic sore throat remedies; Clear Eyes eye drops; Compound W wart removers; Little Remedies and PediaCare pediatric healthcare products; The Doctor’s brand of oral care products; Efferdent and Effergrip denture products; Luden's drops; Dramamine motion sickness products; BC and Goody's analgesic powders; Beano gas prevention; Gaviscon antacids; and Debrox ear drops, as well as Dermoplast first-aid products; Murine eye and ear care products; NasalCrom allergy prevention relief product; New-Skin liquid bandage; Wartner wart removers; Fiber Choice fiber laxative supplements; and Ecotrin aspirin. The Household Cleaning segment markets household cleaning products, such as Chore Boy scrubbing pads and sponges; Comet abrasive powders, creams, liquids, and non-abrasive sprays; and Spic and Span dilutables, sprays for counter tops, and glass cleaners. Prestige Brands Holdings, Inc. distributes its products through various retail channels, including drug, grocery, dollar, and club stores, as well as supermarkets and mass merchandisers. The company was founded in 1996 and is headquartered in Tarrytown, New York.

155 Employees
Last Reported Date: 05/19/14
Founded in 1996

prestige brands holdings inc (PBH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $700.0K
Chief Financial Officer
Total Annual Compensation: $450.0K
Senior Vice President of International
Total Annual Compensation: $257.5K
Vice President of Business Development, Gener...
Total Annual Compensation: $345.0K
Executive Vice President of Sales & Marketing
Total Annual Compensation: $415.0K
Compensation as of Fiscal Year 2014.

prestige brands holdings inc (PBH) Key Developments

Prestige Brands Holdings, Inc. Presents at Sidoti & Company, LLC's 19th Annual Emerging Growth Research Institutional Investor Forum, Mar-16-2015

Prestige Brands Holdings, Inc. Presents at Sidoti & Company, LLC's 19th Annual Emerging Growth Research Institutional Investor Forum, Mar-16-2015 . Venue: The Grand Hyatt Hotel, 109 E 42nd St., New York, NY 10017, United States.

Prestige Brands Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014; Revised Earnings Guidance for the Year 2015

Prestige Brands Holdings, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales were $196,435,000 against $143,713,000 a year ago. Total revenues were $197,606,000 against $144,871,000 a year ago. Operating income was $56,993,000 against $40,458,000 a year ago. Income before income taxes was $33,534,000 against $4,186,000 a year ago. Net income was $21,293,000 against $3,130,000 a year ago. Diluted earnings per share were $0.40 against $0.06 a year ago. Non-GAAP EBITDA was $63,280,000 against $29,090,000 a year ago. Non-GAAP adjusted EBITDA was $69,131,000 against $44,102,000 a year ago. Adjusted net income was $25.4 million or $0.48 per share against $15.6 million or $0.30 per share a year ago. For the nine months, the company reported net sales were $520,981,000 against $450,862,000 a year ago. Total revenues were $524,577,000 against $454,328,000 a year ago. Operating income was $146,314,000 against $143,661,000 a year ago. Income before income taxes was $90,009,000 against $75,045,000 a year ago. Net income was $54,488,000 against $56,614,000 a year ago. Diluted earnings per share were $1.04 against $1.08 a year ago. Net cash provided by operating activities was $104,142,000 against $80,860,000 a year ago. Purchases of property and equipment were $3,700,000 against $2,658,000 a year ago. Non-GAAP EBITDA was $159,414,000 against $138,855,000 a year ago. Non-GAAP adjusted EBITDA was $183,393,000 against $155,519,000 a year ago. Adjusted net income was $73.3 million or $1.39 per share against $61.3 million or $1.17 per share a year ago. At December 31, 2014, the company's net debt was $1,622 million. The company revised earnings guidance for the year 2015. The company has increased the low end of adjusted its full-year EPS guidance range from $1.75 to $1.85 per share to $1.82 to $1.85 per share. For the year, the company expects GAAP EPS range from $1.35 to $1.38. Revenue growth is expected at the high end of the company's previous outlook of 15-18%. The update is driven by anticipated organic growth in the legacy business during the fourth quarter. The company also expects GAAP net cash provided by operating activities of $146 million, Non-GAAP adjusted free cash flow of $155 million.

Prestige Brands Holdings, Inc. to Report Q3, 2015 Results on Feb 05, 2015

Prestige Brands Holdings, Inc. announced that they will report Q3, 2015 results at 9:00 AM, Eastern Standard Time on Feb 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBH:US $42.36 USD +0.99

PBH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $21.70 USD -0.26
Inter Parfums Inc $32.63 USD +0.58
Lifetime Brands Inc $15.37 USD -0.075
WD-40 Co $88.26 USD +2.70
Zep Inc $16.88 USD -0.11
View Industry Companies
 

Industry Analysis

PBH

Industry Average

Valuation PBH Industry Range
Price/Earnings 31.1x
Price/Sales 3.2x
Price/Book 3.6x
Price/Cash Flow 25.4x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRESTIGE BRANDS HOLDINGS INC, please visit www.prestigebrandsinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.